AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 APR 2 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Vaccines containing live attenuated Bacillus anthracis or Bacillus subtilis expressing recombinant protective antigen (rPA) were made more potent by adding a promoter trap system based on based on various gfp reporter genes, according to a report in Infection and Immunity.
"Accordingly, a B. anthracis library of 6000 clones harboring plasmids with chromosomal B. anthracis DNA fragments inserted upstream from gfpuv was constructed," reported Orit Gat and colleagues at the Israel Institute for Biological Research in Ness Ziona. "Based on fluorescence intensity, 57 clones carrying potentially strong promoters were identified, some of which were DNA sequenced."
The investigators found that Pntr (251 bp) was the most potent promoter for B. anthracis, increasing its expression of rPA 500-fold over the native pagA promoter and 70-fold over Pamy, the alpha-amylase promoter.
"The number of cell-associated pre-PA molecules in B. anthracis was found to correlate well with the strength of the promoter," said Gat and associates (Use of a promoter trap system in Bacillus anthracis and Bacillus subtilis for the development of recombinant protective antigen-based vaccines. Infect Immun, 2003;71(2):801-813).
The level of mature PA secreted appeared to have an upper boundary, however, and did not surpass that allowed by Pamy. In addition, when ...
Source: HighBeam Research, Promoter trap system increases expression of protective antigen.